PASITHEA THERAPEUTICS CORP. Impairment of Leasehold
PASITHEA THERAPEUTICS CORP. (KTTA) reported Impairment of Leasehold of $3.20 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLeasehold · last filed 2026-03-30
- PASITHEA THERAPEUTICS CORP. impairment of leasehold for the quarter ending 2025-12-31 was $0.00.
- PASITHEA THERAPEUTICS CORP. impairment of leasehold for the quarter ending 2025-09-30 was $0.00.
- PASITHEA THERAPEUTICS CORP. impairment of leasehold for the quarter ending 2025-06-30 was $7.00.
- PASITHEA THERAPEUTICS CORP. impairment of leasehold for the quarter ending 2025-03-31 was $3.19K.
- PASITHEA THERAPEUTICS CORP. impairment of leasehold for fiscal 2025 was $3.20K.
| Period end | Impairment of Leasehold 3 month | Impairment of Leasehold 6 month | Impairment of Leasehold 9 month | Impairment of Leasehold 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $0.00 derived: sum of 2 quarters · filed 2026-03-30 | $7.00 derived: sum of 3 quarters · filed 2026-03-30 | $3.20K 10-K · filed 2026-03-30 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $7.00 derived: sum of 2 quarters · filed 2025-11-13 | $3.20K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $7.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $3.20K 10-Q · filed 2025-08-14 | ||
| 2025-03-31 | $3.19K 10-Q · filed 2025-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |